Latest News

Latest News

News from the World Hepatitis Alliance

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Pages

News from infohep

Prescribers of opioid substitutes lack funding, facilities and guidelines to treat hepatitis C, global survey reveals

24 Jun 2019 aidsmap.com
Only thirty percent of physicians who prescribe opioid substitution therapy to people who inject drugs have also prescribed direct-acting antivirals...

Risk of Parkinson's disease lower in people treated for hepatitis C

18 Jun 2019 Keith Alcorn
People with hepatitis C who received interferon-based treatment were less likely to develop Parkinson’s disease, a large study from Taiwan has...

Hepatitis C more stigmatising than HIV: gay men’s attitudes towards hepatitis C reinfection

13 Jun 2019 aidsmap.com
Qualitative research with HIV-positive gay and bisexual men in Australia who had been cured of hepatitis C infection revealed that having hepatitis C...

Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

11 Jun 2019 Roger Pebody
There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in Western Europe, researchers...

France switches to simplified pangenotypic hepatitis C treatment

5 Jun 2019 Keith Alcorn
French health authorities have recommended that everyone diagnosed with hepatitis C should be treated with a pangenotypic direct-acting antiviral...

How much can 'Netflix'-style pricing for hepatitis C drugs save?

3 Jun 2019 Keith Alcorn
A `Netflix`-style pricing agreement that allows the Australian government to treat an unlimited number of people with hepatitis C for AU$1 billion...

What do people who inject drugs think of point-of-care HCV testing?

20 May 2019 Keith Alcorn
Point-of-care testing to diagnose hepatitis C virus (HCV) infection has the potential to eliminate the need for multiple appointments to confirm...

World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans

30 Apr 2019 Keith Alcorn
The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people...

Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment

24 Apr 2019 Keith Alcorn
Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing an internationally agreed target...

Emricasan misses study endpoint for improving portal hypertension in people with NASH

24 Apr 2019 Liz Highleyman
The experimental caspase inhibitor emricasan did not meet the statistical threshold for improvement of portal hypertension in people with non-...